Determinants of liver damage associated with intravenous methylprednisolone pulse therapy in Graves' ophthalmopathy

Thyroid

Volumn 17, Issue 4, 2007, Pages 357-362

  Le Moli, Rosario ^a   Baldeschi, Lelio ^a   Saeed, Peerooz ^a   Regensburg, Noortje ^a   Mourits, Maarten P ^a   Wiersinga, Wilmar M ^a,b  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; GLUCOCORTICOID; METHYLPREDNISOLONE; PREDNISONE;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DOSE RESPONSE; DRUG EFFICACY; DRUG PULSE THERAPY; DRUG SAFETY; DRUG TOLERABILITY; ENDOCRINE OPHTHALMOPATHY; FATTY LIVER; FEMALE; FOLLOW UP; HEART PALPITATION; HUMAN; HYPERGLYCEMIA; IRRITABILITY; LIVER CELL; LIVER FUNCTION; LIVER INJURY; MALE; OPTIC NERVE DISEASE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SIDE EFFECT; VIRUS HEPATITIS;

ADULT; ALANINE TRANSAMINASE; ASPARTATE AMINOTRANSFERASES; FEMALE; FOLLOW-UP STUDIES; GRAVES OPHTHALMOPATHY; HUMANS; INFUSIONS, INTRAVENOUS; LIVER FAILURE; MALE; METHYLPREDNISOLONE; MIDDLE AGED; PROSPECTIVE STUDIES;

EID: 34248657570     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.2006.0267     Document Type: Article

References (16)

1. Wiersinga WM, Prummel MF 2002 Graves' ophthalmopathy: a rational approach to treatment. Trends Endocrinol Metab 13:280-287.
2. Marcocci C, Bartalena L, Tanda ML, Manetti L, Dell'Unto E, Rocchi R, Barbesino G, Mazzi B, Bartolomei MP, Lepri P, Cartci F, Nardi M, Pinchera A 2001 Comparison of the effectiveness and tolerability of intravenous or oral glucocorticoids associated with orbital radiotherapy in the management of severe Graves' ophthalmopathy: results of a prospective, single-blind, randomized study. J Clin Endocrinol Metab 86:3562-3567.
3. Kauppinen-Mäkelin R, Karma A, Leinonen E, Löyttyniemi E, Salonen O, Sane T, Setälä K, Viikari J, Heufelder A, Välimäki M 2002 High dose intravenous methylprednisolone pulse therapy verus oral prednisone for thyroid-associated ophthalmopathy. Acta Ophthalmol Scand 80:316-321.
4. Kahaly G, Pitz S, Hommel G, Dittmar M 2005 Randomized, single blind trial of intravenous versus oral steroid monotherapy in Graves' orbitopathy. J Clin Endocrinol Metab 90: 5234-5240.
5. Nagayama Y, Izumi M, Kiriyama T, Yokoyama N, Morita S, Kakezone F, Ohtakara S, Morimoto I, Okamoto S, Nagataki S 1987 Treatment of Graves' ophthalmopathy with high-dose intravenous methylprednisolone pulse therapy. Acta Endocrinol 116:513-518.
6. Kendall-Taylor P, Crombie AL, Stephenson AM, Hardwick M, Hall K 1988 Intravenous methylprednisolone in the treatment of Graves' ophthalmopathy. Brit Med J 297:1574-1578.
7. Wakelkamp IMMG, Baldeschi L, Saeed P, Mourits MP, Prummel MF, Wiersinga WM 2005 Surgical or medical decompression as a first-line treatment of optic neuropathy in Graves' ophthalmopathy? A randomized clinical trial. Clin Endocrinol 63:323-328.
8. Weissel M, Hauff W 2000 Fatal liver failure after high-dose glucocorticoid pulse therapy in a patient with severe thyroid eye disease. Thyroid 10:521.
9. Marino M, Morabito E, Brunetto MR, Bartalena L, Pinchera A, Marocci C 2004 Acute and severe liver damage associated with intravenous glucocorticoid pulse therapy in patients with Graves' ophthalmopathy. Thyroid 14:403-406.
10. Dickinson AJ, Perros P 2001 Controversies in the clinical evaluation of active thyroid-associated orbitopathy: use of a detailed protocol with comparative photographs for objective assessment. Clin Endocrinol 55:283-303.
11. Mourits MP. Prummel MF, Wiersinga WM, Koornneef L 1997 Clinical activity as a guide in the management of patients with Graves' ophthalmopathy. Clin Endocrinal 47:9-14.
12. Prummel MF, Wiersinga WM, Lips P, Sanders GT, Sauerwein HP 1991 The course of biochemical parameters of bone turnover during treatment with corticosteroids. J Clin Endocrinol Metab 72:382-386.
13. Farrell GC. 2002 Drugs and steatohepatitis. Semin Liver Dis 22:185-194.
14. Salvi M, Vannucchi G, Sbrozzi F, Bottari del Castello A, Carnevali A, Fargion S, Beck-Peccoz P 2004 Onset of autoimmune hepatitis during intravenous steroid therapy for thyroid-associated ophthalmopathy in a patient with Hashimoto's thyroiditis: case report. Thyroid 14:631-634.
15. Marino M, Morabito E, Altea MA, Ambrogini E, Olivari F, Brunetto MR, Pollina LE, Campani D, Vitti P, Bartalena L, Pinchera A, Marcocci C 2005 Autoimmune hepatitis during intravenous glucocorticoid pulse therapy for Graves' ophthalmopathy treated successfully with glucocorticoids themselves. J Endocrinol Invest 28:280-284.
16. Dousakis SP, Sevastianos VA, Kalipi P 2002 Acute severe steatohepatitis related to prednisolone therapy. Am J Gastroenterol 9:1074-1075.